Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Neural mechanisms of psychedelic visual imagery

View ORCID ProfileDevon Stoliker, Katrin H. Preller, Leonardo Novelli, Alan Anticevic, Gary F. Egan, Franz X. Vollenweider, Adeel Razi
doi: https://doi.org/10.1101/2022.09.07.22279700
Devon Stoliker
1Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Devon Stoliker
  • For correspondence: devon.stoliker{at}monash.edu
Katrin H. Preller
3Department of Psychiatry, Psychotherapy & Psychosomatics, University Hospital for Psychiatry, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Novelli
1Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Anticevic
4Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary F. Egan
1Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC
2Monash Biomedical Imaging, Monash University, Clayton, VIC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz X. Vollenweider
3Department of Psychiatry, Psychotherapy & Psychosomatics, University Hospital for Psychiatry, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeel Razi
1Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC
2Monash Biomedical Imaging, Monash University, Clayton, VIC
5Wellcome Centre for Human Neuroimaging, UCL, London, United Kingdom
6CIFAR Azrieli Global Scholars Program, CIFAR, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Visual alterations under classic psychedelics can include rich phenomenological accounts of eyes-closed imagery. Preclinical evidence suggests agonism of the 5-HT2A receptor may reduce synaptic gain to produce psychedelic-induced imagery. However, this has not been investigated in humans. To infer the directed connectivity changes to visual sensory connectivity underlying psychedelic visual imagery in healthy adults, a double-blind, randomised, placebo-controlled, cross-over study was performed, and dynamic causal modelling was applied to the resting state eyes-closed functional MRI scans of 24 subjects after administration of 0.2mg/kg of the serotonergic psychedelic drug, psilocybin (magic mushrooms), or placebo. The effective connectivity model included the early visual area, fusiform gyrus, intraparietal sulcus, and inferior frontal gyrus. We observed a pattern of increased self-inhibition of both early visual and higher visual-association regions under psilocybin that was consistent with preclinical findings. We also observed a pattern of reduced inhibition from visual-association regions to earlier visual areas that indicated top-down connectivity is enhanced during visual imagery. The results were associated with behavioural measures taken immediately after the scans, suggesting psilocybin-induced decreased sensitivity to neural inputs is associated with the perception of eyes-closed visual imagery. The findings inform our basic and clinical understanding of visual perception. They reveal neural mechanisms that, by affecting balance, may increase the impact of top-down feedback connectivity on perception, which could contribute to the visual imagery seen with eyes-closed during psychedelic experiences.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT03736980

Funding Statement

Heffter Research Institute (Grant No. 1- 190420) Swiss Neuromatrix Foundation (Grant No. 2016-0111), Swiss National Science Foundation under the framework of Neuron Cofund (Grant No. 01EW1908), Slovenian Research Agency (ARRS) (Grant Nos. J7-8275, J7-6829,Council Discovery Early Career Research Award Fellowship DE170100128 (to AR), Australian Research Council Discovery Project grant DP200100757 (AR), Australian National Health and Medical Research Council Investigator grant 1194910 (AR), Wellcome Centre for Human Neuroimaging supported by core funding from Wellcome grant 203147/Z/16/Z (AR)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data analysed in this paper were collected as part of a previous study (registered at ClinicalTrials.gov (NCT03736980)), which is reported in (Preller et al., 2020, doi: 10.1016/j.biopsych.2019.12.027) and was approved by the Cantonal Ethics Committee of Zurich.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • + Joint Senior Authors

  • This version of the manuscript has been revised to update the list of authors and clarify details in response to feedback. Figures have been updated to provide more clarity on the findings.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 27, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Neural mechanisms of psychedelic visual imagery
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Neural mechanisms of psychedelic visual imagery
Devon Stoliker, Katrin H. Preller, Leonardo Novelli, Alan Anticevic, Gary F. Egan, Franz X. Vollenweider, Adeel Razi
medRxiv 2022.09.07.22279700; doi: https://doi.org/10.1101/2022.09.07.22279700
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Neural mechanisms of psychedelic visual imagery
Devon Stoliker, Katrin H. Preller, Leonardo Novelli, Alan Anticevic, Gary F. Egan, Franz X. Vollenweider, Adeel Razi
medRxiv 2022.09.07.22279700; doi: https://doi.org/10.1101/2022.09.07.22279700

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)